ZEVRA THERAPEUTICS, INC. — All Filings
840 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
25-NSE
3
4
424B2
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
CERT
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DEFC14A
DFAN14A
DRS
DRS/A
DRSLTR
EFFECT
NT 10-Q
POS AM
POS EX
PRE 14A
PREC14A
PREN14A
PRER14A
PRRN14A
REGDEX
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-4
S-4/A
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-002639 | Mar 27, 2026 | — |
| 4 | FORM 4 | 0001612084-26-000002 | Mar 26, 2026 | Mar 24, 2026 |
| 4 | FORM 4 | 0001466562-26-000007 | Mar 19, 2026 | Mar 18, 2026 |
| 3 | FORM 3 | 0001466562-26-000005 | Mar 19, 2026 | Mar 18, 2026 |
| 144 | — | 0001950047-26-002681 | Mar 16, 2026 | — |
| 8-K | 8-K | 0001434647-26-000015 | Mar 16, 2026 | Mar 12, 2026 |
| S-8 | S-8 | 0001434647-26-000013 | Mar 9, 2026 | — |
| 10-K | 10-K | 0001434647-26-000011 | Mar 9, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001434647-26-000009 | Mar 9, 2026 | Mar 4, 2026 |
| 4 | FORM 4 | 0001681098-26-000004 | Feb 10, 2026 | Feb 7, 2026 |
| 4 | FORM 4 | 0001698328-26-000004 | Feb 4, 2026 | Feb 3, 2026 |
| 4 | FORM 4 | 0001945557-26-000004 | Feb 4, 2026 | Feb 3, 2026 |
| 4 | FORM 4 | 0001698328-26-000002 | Feb 2, 2026 | Jan 30, 2026 |
| 4 | FORM 4 | 0001788524-26-000002 | Feb 2, 2026 | Jan 29, 2026 |
| 4 | FORM 4 | 0001910132-26-000002 | Feb 2, 2026 | Jan 29, 2026 |
| 4 | FORM 4 | 0001945557-26-000002 | Feb 2, 2026 | Jan 29, 2026 |
| 4 | FORM 4 | 0001681098-26-000002 | Feb 2, 2026 | Jan 29, 2026 |
| 144 | — | 0001950047-26-000828 | Feb 2, 2026 | — |
| 144 | — | 0001950047-26-000775 | Jan 30, 2026 | — |
| 144 | — | 0001950047-26-000773 | Jan 30, 2026 | — |
| 144 | — | 0001950047-26-000771 | Jan 30, 2026 | — |
| 144 | — | 0001950047-26-000770 | Jan 30, 2026 | — |
| 144 | — | 0001950047-26-000769 | Jan 30, 2026 | — |
| 4 | FORM 4 | 0001488774-26-000002 | Jan 7, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001434647-25-000018 | Dec 17, 2025 | Dec 11, 2025 |
| 4 | FORM 4 | 0001584516-25-000009 | Dec 9, 2025 | Dec 2, 2025 |
| 3 | FORM 3 | 0001584516-25-000007 | Dec 9, 2025 | Dec 2, 2025 |
| 8-K | 8-K | 0001434647-25-000015 | Dec 2, 2025 | Nov 26, 2025 |
| 8-K | 8-K | 0001193125-25-289865 | Nov 20, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-005021 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-004878 | Nov 13, 2025 | — |
| 10-Q | 10-Q | 0001434647-25-000011 | Nov 5, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001434647-25-000009 | Nov 5, 2025 | — |
| 4 | FORM 4 | 0001681098-25-000005 | Oct 10, 2025 | — |
| 144 | — | 0001950047-25-007899 | Oct 10, 2025 | — |
| 4 | FORM 4 | 0001288232-25-000009 | Sep 16, 2025 | Sep 12, 2025 |
| 4 | FORM 4 | 0001610064-25-000011 | Sep 15, 2025 | Sep 12, 2025 |
| 4 | FORM 4 | 0001437749-25-027456 | Aug 20, 2025 | Aug 19, 2025 |
| 10-Q | 10-Q | 0001628280-25-039967 | Aug 12, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001628280-25-039883 | Aug 12, 2025 | — |
| 4 | FORM 4 | 0001437749-25-021577 | Jun 30, 2025 | Jun 26, 2025 |
| 144 | — | 0001950047-25-004639 | Jun 26, 2025 | — |
| 4 | FORM 4 | 0001437749-25-021183 | Jun 24, 2025 | Jun 21, 2025 |
| 4 | FORM 4 | 0001437749-25-019050 | May 30, 2025 | May 29, 2025 |
| 4 | FORM 4 | 0001437749-25-019049 | May 30, 2025 | May 29, 2025 |
| 4 | FORM 4 | 0001437749-25-019048 | May 30, 2025 | May 29, 2025 |
| 4 | FORM 4 | 0001437749-25-019047 | May 30, 2025 | May 29, 2025 |
| 4 | FORM 4 | 0001437749-25-019046 | May 30, 2025 | May 29, 2025 |
| 4 | FORM 4 | 0001437749-25-019045 | May 30, 2025 | May 29, 2025 |
| 4 | FORM 4 | 0001437749-25-019044 | May 30, 2025 | May 29, 2025 |